Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 4 | 031L20A | IM |
sore arm; minor rash/got a whole torso body rash; chills; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), RASH (minor rash/got a whole torso body rash), CHILLS (chills) and PYREXIA (low-grade fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A, 001B21A, 013F21A and 051B22A) for COVID-19 prophylaxis. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (sore arm), RASH (minor rash/got a whole torso body rash), CHILLS (chills) and PYREXIA (low-grade fever). In 2021, RASH (minor rash/got a whole torso body rash) and PYREXIA (low-grade fever) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and CHILLS (chills) outcome was unknown. No concomitant medication was reported. It was stated patient developed reactions after getting a dose from Moderna COVID-19 vaccines. It was stated patient received Moderna COVID-19 vaccine since 2021. It was stated that the reaction on her first dose in February 2021 was a "minor rash" which was stated that was not so bad." In contrast to her 2nd dose in March 2021 which was stated to be a "major reaction". It was stated that in March 2021, patient got a whole torso body rash" and described the rash as "major rash" which lasted for 1 week. It was also added along with the rash that patient had sore arm, chills, and a low-grade fever. It was also narrated that she also received a dose in November 2021 which stated to experienced low grade fever that lasted for few hours and a minor rash for a couple of days. It was unknown if the patient experienced any additional symptoms/events. No treatment information was reported. This case was linked to MOD-2025-789705, MOD-2025-789706, MOD-2025-789707 (Patient Link).